Healthcare sector remains attractive due to ongoing innovation, defensive qualities, and discounted valuations despite near-term policy uncertainty. Small- and mid-cap biotech stocks are pressured by ...

Life sciences innovation in advanced economies is under threat—not from a lack of talent, ideas, or scientific leadership, but from policy failures. The EU, Canada, Japan, and other major markets are ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

The future of healthcare is here—and it’s digital. From accelerating research to improving patient care, the integration of AI, data analytics and cutting-edge technologies is driving the industry ...